BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE and LOSS OF CONSCIOUSNESS

10 reports of this reaction

1.5% of all BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE reports

#14 most reported adverse reaction

Overview

LOSS OF CONSCIOUSNESS is the #14 most commonly reported adverse reaction for BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, manufactured by Foundation Consumer Brands. There are 10 FDA adverse event reports linking BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE to LOSS OF CONSCIOUSNESS. This represents approximately 1.5% of all 662 adverse event reports for this drug.

BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE has an overall safety score of 85 out of 100. Patients taking BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE who experience loss of consciousness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

LOSS OF CONSCIOUSNESS10 of 662 reports

LOSS OF CONSCIOUSNESS is a less commonly reported adverse event for BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, but still significant enough to appear in the safety profile.

Other Side Effects of BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE

In addition to loss of consciousness, the following adverse reactions have been reported for BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE:

Frequently Asked Questions

Does BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE cause LOSS OF CONSCIOUSNESS?

LOSS OF CONSCIOUSNESS has been reported as an adverse event in 10 FDA reports for BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is LOSS OF CONSCIOUSNESS with BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE?

LOSS OF CONSCIOUSNESS accounts for approximately 1.5% of all adverse event reports for BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, making it a notable side effect.

What should I do if I experience LOSS OF CONSCIOUSNESS while taking BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE?

If you experience loss of consciousness while taking BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.